Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase

SHANGHAI, Jan. 2, 2024 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that Dr. Hai Wu, R&D VP of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase in San Francisco, United States….

Click here to view original post

Advertisement — Advertise with Biotech Networks